New York State Psychiatric Institute
Clinical trials sponsored by New York State Psychiatric Institute, explained in plain language.
-
Could a common cold sore virus be linked to Alzheimer's? new study tests antiviral treatment
Disease control CompletedThis study tested whether a common antiviral drug, valacyclovir, could slow memory decline in people with mild cognitive impairment (MCI) who also carry the herpes simplex virus. Fifty participants took either the drug or a placebo for 52 weeks. The goal was to see if treating th…
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Nerve block may offer new way to beat opioid withdrawal
Symptom relief CompletedThis small pilot study tested whether blocking a nerve cluster called the SPG can reduce withdrawal symptoms in people with opioid use disorder. Only 3 people took part, and the goal was to see if the idea is worth studying further. The study did not provide addiction treatment—i…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
Could ketamine silence the ringing? new study explores
Symptom relief CompletedThis study tested whether a single dose of ketamine, a drug that affects brain chemicals, can reduce tinnitus (ringing in the ears). 42 adults with hearing loss and tinnitus received both ketamine and a placebo on different days. The goal was to see if ketamine changes levels of …
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Apr 29, 2026 15:01 UTC